{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:52Z","timestamp":1786119472783,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/iae.0b013e3181b4f125","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T01:44:03Z","timestamp":1265075043000},"page":"254-259","source":"Crossref","is-referenced-by-count":29,"title":["INTRAVITREAL TRIAMCINOLONE AS AN ADJUNCT TO STANDARD LASER THERAPY IN COEXISTING HIGH-RISK PROLIFERATIVE DIABETIC RETINOPATHY AND CLINICALLY SIGNIFICANT MACULAR EDEMA"],"prefix":"10.1097","volume":"30","author":[{"given":"AHMAD","family":"MIRSHAHI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAMIDEH","family":"SHENAZANDI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALIREZA","family":"LASHAY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUSHANG","family":"FAGHIHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ASOO","family":"ALIMAHMOUDI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SEYEDSAEID","family":"DIANAT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00125-002-0990-7","article-title":"Diabetic retinopathy: a clinical update.","volume":"45","author":"Porta","year":"2002","journal-title":"Diabetologia"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.ophtha.2003.05.008","article-title":"Quantifying alterations of macular thickness before and after pan-retinal photocoagulation in patients with severe diabetic retinopathy and good vision.","volume":"110","author":"Shimura","year":"2003","journal-title":"Ophthalmology"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/archopht.122.12.1801","article-title":"Vitreous levels of vascular endothelial growth factor and stromalderived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.","volume":"122","author":"Brooks","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00417-005-0069-5","article-title":"Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.","volume":"244","author":"Avci","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema.","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema.","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/archopht.123.7.939","article-title":"A standardized method for reporting changes in macular thickening using optical coherence tomography.","volume":"123","author":"Chan","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archopht.1992.01080200135041","article-title":"Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation.","volume":"110","author":"Wilson","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archopht.1985.01050100143037","article-title":"Clearance of triamcinolone from vitreous.","volume":"103","author":"Scholes","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","article-title":"Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.","volume":"132","author":"Jonas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00006982-200502000-00003","article-title":"Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for coexisting diabetic macular edema and proliferative diabetic retinopathy.","volume":"25","author":"Zacks","year":"2005","journal-title":"Retina"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00006982-200602000-00002","article-title":"Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.","volume":"26","author":"Zein","year":"2006","journal-title":"Retina"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2004.05.025","article-title":"Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment. Three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.","volume":"111","author":"Sutter","year":"2004","journal-title":"Ophthalmology"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ophtha.2006.02.065","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema. Two-year results of a double-masked, placebo-controlled, randomized clinical trial.","volume":"113","author":"Gillies","year":"2006","journal-title":"Ophthalmology"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ajo.2005.05.021","article-title":"Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.","volume":"140","author":"Avitabile","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archopht.124.5.653","article-title":"Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema.","volume":"124","author":"Kang","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archopht.124.5.643","article-title":"Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy.","volume":"124","author":"Bandello","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0420.2007.00940.x","article-title":"Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.","volume":"86","author":"Margolis","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10792-007-9042-0","article-title":"Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema. Combined IVTA and laser treatment for PDR with CSMO.","volume":"26","author":"Kaderli","year":"2005","journal-title":"Int Ophthalmol"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ophtha.2008.06.015","article-title":"A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal\/Grid Photocoagulation for Diabetic Macular Edema.","volume":"115","year":"2008","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0b013e3181b4f125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:19:02Z","timestamp":1786040342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201002000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181b4f125","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}